Mast Cell Activation Symptomatology (Part 3 of 3)

The video features discussions from four leading experts in mast cell research on the symptoms and management of mast cell activation disorders. They talk about using histamine blockers (H1 and H2) as initial treatment and potentially adding leukotriene inhibitors for patients without elevated typical biomarkers like serum tryptase but still experiencing symptoms. They discuss challenges in diagnosing these disorders due to the lack of clear diagnostic criteria in some cases and the work being done to define them better. Natural compounds like quercetin and luteolin, which can inhibit mast cell activation, are also mentioned as potential treatments. The video is produced by The Mastocytosis Society and aims to enhance understanding and provide support for those affected by mast cell disorders.